CClinicalTrials.gg
Status unknownNCT01476579Updated Apr 18, 2019

Comparison of Low-radiation Dose CT Angiography With Invasive Coronary Angiography in Stable Coronary Disease

An interventional study of Cardiac Computer Tomography in Coronary Artery Disease, sponsored by University Hospital of North Norway. Status unknown at 1 site in Norway. Open to participants aged 30 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-04-18.

Sponsored by University Hospital of North Norway · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Apr 2019), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
769
Allocation
Not applicable
Ages
30 Years to 90 Years
Sex
All
01

Study summary

This study is evaluating the performance of modern CT coronar angiography with low radiation technique compared to conventional invasive coronar angiography. The patients recruited will already be accepted for invasive coronary angiography based on clinical presentation, ECG and biochemical parameters. An "all-comers" design to avoid selection bias and no additional B-blockers will be used prior to CT angiography. The hypothesis is that it is possible to rule out significant coronary artery disease with sensitivity > 95 % and negative predictive value > 95 % with very low radiation doses.

Read the detailed description

Conventional invasive coronary angiography (CICA) is associated with few but serious complications. It is time consuming for the patient and incur costs to the health institution due to the post-procedure observation needed. Coronary computer tomography angiography (CCTA) is a good alternative to CICA to rule out coronary artery disease (CAD). Moderate to excellent sensitivity and negative predictive values have been reported with 64-slice CT angiography. The main ethical problem has been the radiation doses given to the patient during CT angiography which was high >10 millisievert(mSv). With 265 or higher slice CT machines and radiation dose reduction techniques, it is possible to evaluate coronary anatomy with radiation doses below 1 mSv. Heart rate reduction with B-blockers is in most cases not necessary with new generation CT machines but is recommended in guidelines.

800 patients already accepted for CICA based on clinical information will be scheduled to undergo CCTA prior to invasive coronary angiography. Coronary anatomy will be described according to American Heart Association (AHA) classification with 17 segment analysis. The main purpose of the study is to achieve high sensitivity and high negative predictive value with CT angiography. Radiation doses in relation to gender and body mass index (BMI) will be monitored. In addition we will measure coronary calcification (Agatson score) and look at any association to the Vitamin D and calcium metabolism. Patient reported quality of life evaluation with validated questionnaires and long term follow up (5 and 10 years) regarding clinical endpoints.

02

Conditions studied

  • Coronary Artery Disease

Keywords

  • Coronary CT
  • Sensitivity
  • Specificity
  • Radiation
  • Tomography, X-Ray Computed
  • Coronary angiography
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 769 is above the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

University Hospital of North Norway is the lead sponsor of 150 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. 800 Patients who are scheduled to undergo conventional invasive coronary angiogram will be recruited at the University hospital of North Norway, Tromsø.

Exclusion criteria

Exclusion Criteria:

  1. Acute coronary syndrome with positive high sensitive troponin.
  2. Renal failure with glomerular filtration rate (GFR) \< 30
  3. Contraindication to contrast medium
  4. Symptomatic Tachycardia >110 or bradycardia \< 40
  5. Pregnancy
  6. Lack of informed consent
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
769 participants (actual)

Study arms

  • Other
    Non-invasive CT coronary angiography

    This study is evaluating diagnostic accuracy of non-invasive CT coronary angiography with invasive coronary angiography.

    Device: Cardiac Computer Tomography

Interventions

  • DeviceCardiac Computer Tomography

    Compare Cardiac CT with reference standard wich is conventional invasive coronary angiography.

06

What researchers measure

Primary outcomes

  1. Sensitivity and specificity

    The results from the CT coronary angiography will be compared with the results from the conventional invasive coronary angiography which in this respect is considered the "gold standard". The sensitivity and specificity for the CT angiography regarding detection of significant coronary stenosis (ie more than 50 % lumen narrowing with the angiographic result as reference) and for revascularisation will be calculated separately.

    Time frame: 24 hours

Secondary outcomes

  1. Change in quality of life and symptom score

    Change from baseline in quality of life and symptoms as measured with SF-12, HADS og SEATTLE will be assessed both for patients with and without significant coronary pathology with postal questionnaires at 6 months, 1 and 3 years after the CT angiography

    Time frame: 6 months, 1 and 3 years

  2. Coronary calcium score impact on pretest coronary risk scoring and prognosis

    The change in pretest probability for detection of significant stenosis and revascularisation by calcium score will be calculated in addition to prediction of 5 and 10 year fatal and non fatal cardiovascular events.

    Time frame: 24 hours, 5 and 10 years

  3. Vitamin D and other novel cardiovascular risk factors

    The association of vitamin D levels (25OHD) and Single Nucleotide Polymorphism (SNP) related to vitamin D and calcium metabolism to presence of coronary plaques and their calcium content will be analysed as well as risk of fatal and non fatal coronary events. When events are registered other new novel risk markers detected in the Tromso Study will be measured in a nested case control design.

    Time frame: 24 hours, 5 and 10 years

  4. Real life radiation risk with new CT scanners and conventional invasive angiography

    The radiation doses will be measured independent of supplier software for both procedures and compared. Impact of risk factors on radiation dosage and image quality will be determined.

    Time frame: 24 hours

07

Study locations

1 site
  • University Hospital of North Norway
    Tromsø, 9038, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01476579
Lead sponsor
University Hospital of North Norway
Collaborators
University of Tromso
Responsible party
Sponsor
First posted
Nov 22, 2011
Start date
Jan 2012
Primary completion
Dec 2012
Completion
Jan 2022 (estimated)
Last update
Apr 18, 2019

Study contacts

AMJID IQBAL, MD, PhD
principal investigator · University Hospital of North Norway

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion